The receipt of a CE mark in Europe for Affirm follows the software gaining US market clearance from the FDA in October 2020.

Investors need to pay close attention to Hologic (HOLX) stock based on the movements in the options market lately.

Hologic Inc. closed 24.50% short of its 52-week high of $84.67, which the company reached on August 9th.

Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Aptima® SARS-CoV-2 assay, which was first granted ...

New Mexico Educational Retirement Board cut its position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 3.5% in ...

The health care sector is likely reacting to the uncertainty created by the effect of federal budget cuts now being ...

Hologic, Inc. (NASDAQ:HOLX), a leading medical technology company specializing in women's health, diagnostics, and medical imaging systems, has been navigating a complex market landscape characterized ...

The next generation of stars has arrived as Mirra Andreeva takes on Clara Tauson in the Dubai Duty Free Tennis Championships ...

Microba Life Sciences (ASX:MAP), which has technology for measuring the gut microbiome, has a strategic partnership deal with pathology and radiology giant Sonic Healthcare (ASX:SHL), which acquired ...